This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice (http://www2.deloitte.com/ca/en/legal/cookies.html) for more information on the cookies we use and how to delete or block them.
The full functionality of our site is not supported on your browser version, or you may have 'compatibility mode' selected. Please turn off compatibility mode, upgrade your browser to at least Internet Explorer 9, or try using another browser such as Google Chrome or Mozilla Firefox.
This Clearly IFRS discusses the proposed amendment to IAS 1 Presentation of Financial Statements set out in Exposure Draft ED/2020/3 Classification of Liabilities as Current or Non-current—Deferral of Effective Date (the ‘ED’) published by the International Accounting Standards Board (IASB) in May 2020.
The convergence of the technology and health care/life sciences industries has caused unique challenges for management within these sectors, particularly in the areas of capitalized software and revenue recognition. This publication is aimed at identifying and providing guidance on the most difficult technical accounting issues related to these topics. In addition, this guide provides our perspective on the emerging health tech marketplace as well as relevant research on health tech investment trends.
This Clearly IFRS addresses the proposed amendments to IFRS 9 Financial Instruments, IAS 39 Financial Instruments: Recognition and Measurement, IFRS 7 Financial Instruments: Disclosures, IFRS 4 Insurance Contracts and IFRS 16 Leases set out in Exposure Draft ED/2020/1 Interest Rate Benchmark Reform—Phase 2: Proposed amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (the ‘ED’) published by the International Accounting
Standards Board (IASB) in April 2020.
This special edition sets out financial reporting issues that may be relevant for years ending on or after December 31, 2019 as a result of areas of regulatory focus, the current economic environment or changes in accounting standards.
Calendar-year-end public business entities adopted the FASB’s new leasing standard (ASC 842) on January 1, 2019. This Heads Up outlines the ASC 842 disclosure requirements, elaborates on some of those requirements, and provides examples of related SEC comments issued to registrants in 2019.
This Heads Up extracts key insights from this year’s three-day AICPA Conference on Current SEC and PCAOB Developments. The conference featured speeches and panel discussions by members of the SEC, PCAOB, FASB, and other professional groups on current accounting, reporting, and auditing practice issues.
Does your private company have tax planning shares? If yes, please check out our publication that explains what you need to know about the amendments to Section 3856, Financial Instruments for the accounting for such shares. Our publication walks through the new model for classifying the shares as equity or as a financial liability and provides practical insights, examples, decision trees and a transition checklist to support your understanding of the amendments and things you need to think about when implementing the changes.
This Clearly IFRS addresses the recent amendments to IFRS 9 Financial Instruments, IAS 39 Financial Instruments: Recognition and Measurement and IFRS 7 Financial Instruments: Disclosures that have been published by the International Accounting Standards Board (IASB).
This publication explores some of the key differences between IFRS® Standards and U.S. GAAP that are effective as of January 1, 2020, for public business entities with a calendar-year annual reporting period. Although this Roadmap does not capture all the differences that exist between the two sets of standards, it focuses on differences that are commonly found in practice.
This publication contains extracts of frequently issued SEC staff comments, analysis of those extracts, and links to resources that are relevant to SEC filers. Other features include (1) an update on the SEC’s priorities; (2) a summary of comment letter trends related to the top 10 topics of frequent comment in the 12-month period ended July 31, 2019; and (3) topics of focus related to disclosures associated with financial statement accounting, SEC reporting, initial public offerings, foreign private issuers, and industry-specific matters. Appendix F of the Roadmap summarizes the changes made in the 2019 edition.
This Clearly IFRS addresses the proposed amendments to IAS 1 'Presentation of Financial Statements' and IFRS Practice Statement 2 'Making Materiality Judgements' set out in Exposure Draft ED/2019/6 'Disclosure of Accounting Policies (Proposed amendments to IAS 1 and IFRS Practice Statement 2)' published by the International Accounting Standards Board in August 2019.
This Heads Up discusses the critical audit matters (CAMs) that were communicated in auditors’ reports for all large accelerated filers with fiscal years ending June 30, 2019. The CAMs most often identified were related to goodwill and intangible assets, revenue, and income taxes.
